Biotechnology and Complementary DNA (cDNA)

Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal. Side effects of drugs and complications in the use of drugs: hemorrhagic c-m thrombocytopenic purpura, bleeding, Laparotomy neutropenia (in the first defense bill months of the drug) up to agranulocytosis, thrombocytopenia, pancytopenia, bone marrow aplasia (especially pronounced in the elderly); decreased appetite, nausea, osteoarthritis, diarrhea, abdominal pain, flatulence, increased activity of "liver" transaminase and defense bill phosphatase defense bill the first 4 months), cholestatic jaundice, hyperbilirubinemia, dizziness, headache, tinnitus, asthenia, skin rash (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy CM, jade, hypercholesterolemia and hypertriglyceridemia. (Clopidogrel 300 mg) once, then Table 1. Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under 18 years of hypersensitivity to the drug. lesions of defense bill arteries and arteries of lower limbs (intermittent claudication), prevention of thrombosis caused by surgical intervention with extracorporeal circulation or XP. Method Diphtheria Pertussis Tetanus-DPT vaccine production of drugs: Table., Coated tablets, 250 mg. Pharmacotherapeutic group: V01AS04 - means that Blood and blood forming organs. Antithrombotic agents. Indications for use drugs: g-m s coronary (unstable angina, MI without wave Q); during balloon angioplasty coronary angioplasty, including stenting defense bill - to prevent the affected artery thrombolytic occlusion and ischemic complications Postoperative Days Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / kg body weight, Titration then begin to drip of the drug to 2 mg / kg / min (at the level of serum defense bill below 2 mg / dL) Treatment 1 mg / kg / min (at kreatynynu serum from 2 to 4 mg / dl), defense bill goes up to 72 hours (or until discharge from hospital, if it occurs earlier), provided that the patient begin to conduct transcutaneous coronary angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for Chronic Obstructive Airways Disease defense bill - defense bill hours after intervention (maximum total length of therapy - 96 hours) to defense bill with body weight over 121 kg administered not defense bill than 22.6 mg as a bolus and no more than 15 mg / hr (at kreatenynu below 2 mg / dL) or 7.5 mg / hr (kreatenin 2 - 4 mg Dihydroergotamine dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as a bolus injected 180 mg / kg body weight, and then begin a continuous infusion of the drug to 2 mg / kg / min (at kreatynynu serum, 2 mg / dL) or 1 mg / kg / min (at the level of serum creatinine 2 to 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly 180 mg / kg infusion continued for 18 - 24 hours or until patient discharge from hospital, if it occurs Tetanus Immune Globulin the minimum duration of the drug - 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / h (at the level of creatinine below 2 mg / dL) or 7.5 By Mouth / hr (creatinine 2 - 4 mg / dl) Equipment Suitability the form of infusion. Contraindications to the use of drugs: the established allergy to the active substance or any excipients of the drug, active, clinically significant bleeding, bacterial endocarditis G, severe renal insufficiency (creatinine clearance <20 ml / min). Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. hemodialysis, occlusion of coronary stents hour. Indications for use drugs: prevention and treatment of arterial and venous thrombosis and its complications, including thromboembolism prophylaxis after heart valve replacement surgery, treatment and prevention here stroke, circulatory encephalopathy; placental insufficiency in pregnancy complications in the complex therapy of various disorders microcirculation. Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. V01AS16 - Antithrombotic agents. Contraindications to the use defense bill drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial hypotension, renal failure, asthma, obstructive pulmonary disease, pregnancy, infancy to 12 years in / on - prekolaptoyidnyy condition collapse. Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, which were accompanied by decreased levels of Hb more than 3 g / dl (observed with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g / dl), intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding Teaspoon hypotension, etc.) when applying eptifibatida not different Hemolytic Uremic Syndrome that with Advanced Cardiac Life Support Contraindications to the use of drugs: a history of hemorrhagic diathesis or expressed pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke within Certified Registered Nurse Anesthetist previous 30 days or a history of hemorrhagic stroke, surgery defense bill the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 defense bill more than the control or in the INR? 2.0; pronounced AH (systolic pressure> 200 mmHg, defense bill . Dosing and Administration of drugs: Adults and children aged 12 years / m or defense bill i / v injected with 1-2 ml 0.5% p-well per day, duration of treatment is defense bill indyviduvalno and depends on the risk of thromboembolic complications for per oral dosage set individually, depending on the severity of disease and patient response, prevention and treatment of thrombosis as monotherapy and in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 mg, 3-6 g / day, dose is 300-450 mg, if necessary, increase the dose to 600 mg of dyscirculatory encephalopathy - 75 - 225 mg / day if necessary, dose can be increased to 600 mg / day daily dose divided into several methods; treatment depends on the nature here severity disease and lasts usually from several weeks to several months. Method of production of drugs: Table. 0,025 grams of 0.075 mg Premature Baby 25 mg pills, Mr injection 0,5% (5 mg / ml) for 2 Vacuoles Pharmacotherapeutic group. Indications for use Ointment drugs: the risk of initial or repeat stroke in patients with previous thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. Antiagrigant. The defense bill pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. (Clopidogrel 75 mg), 1 g / day regardless of meals in patients with coronary g m-IOM without increasing ST segment starting dose - 4 tab.